Compare Baidu Inc (BIDU) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baidu Inc vs Davita Inc — how do they compare? Baidu Inc trades at $104.5 (market cap $37.11B), while Davita Inc trades at $179.02 (market cap $11.72B). The key difference: Baidu Inc is far larger — about 3.2× Davita Inc's market cap, and Davita Inc is trading nearer its 52-week high, Baidu Inc nearer its low. Which is the better fit depends on your goals.
| BIDU | DVA | |
|---|---|---|
Market Cap | $37.11B | $11.72B |
Sector | Media | Health |
52-Week High | $162.52 | $240.96 |
52-Week Low | $86.76 | $103.87 |
Enterprise Value | $33.74B | $24.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Baidu (BIDU) trades at $109.71, up 0.35% on the day, with a neutral technical signal and bearish moving averages. Recent earnings show a Q1 2026 miss after two prior beats, while revenue declined to $129.08B in 2025. The stock is supported by strong analyst consensus (75% buy ratings) and a $169.80 price target, but faces headwinds from negative operating cash flow and competitive pressures in AI and advertising.
The outlook hinges on AI monetization and Q2 2026 results due August 18. Upside exists if Baidu leverages partnerships with Apple and Lyft, but risks include margin compression and regulatory scrutiny in China. Valuation metrics like P/E of 78.19 suggest high expectations, making execution critical for near-term performance.
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Baidu Inc
Baidu, Inc. operates an Internet search engine. The Company offers algorithmic search, enterprise search, news, MP3, and image searches, voice assistance, online storage, and navigation services. Baidu serves clients globally.
Read more on BIDU →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
